261 related articles for article (PubMed ID: 19282794)
1. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
[TBL] [Abstract][Full Text] [Related]
2. Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: a preliminary animal study.
Subramanian S; Das T; Chakraborty S; Sarma HD; Banerjee S; Samuel G; Venkatesh M
Cancer Biother Radiopharm; 2010 Oct; 25(5):539-43. PubMed ID: 20849309
[TBL] [Abstract][Full Text] [Related]
3. 166Ho-labeled hydroxyapatite particles: a possible agent for liver cancer therapy.
Das T; Chakraborty S; Sarma HD; Venkatesh M; Banerjee S
Cancer Biother Radiopharm; 2009 Feb; 24(1):7-14. PubMed ID: 19216630
[TBL] [Abstract][Full Text] [Related]
4. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ
Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
[TBL] [Abstract][Full Text] [Related]
5. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
6. Preparation and preliminary biological evaluation of a novel 109Pd labeled porphyrin derivative for possible use in targeted tumor therapy.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):16-23. PubMed ID: 17372569
[TBL] [Abstract][Full Text] [Related]
7. Preparation and preliminary biological evaluation of a (166)Ho labeled polyazamacrocycle for possible use as an intravascular brachytherapy (IVBT) agent.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Appl Radiat Isot; 2006 Apr; 64(4):462-9. PubMed ID: 16352432
[TBL] [Abstract][Full Text] [Related]
8. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
[TBL] [Abstract][Full Text] [Related]
9. Hepatic artery injection of Yttrium-90-lipiodol: biodistribution in rats with hepatoma.
Wang SJ; Lin WY; Lui WY; Chen MN; Tsai ZT; Ting G
J Nucl Med; 1996 Feb; 37(2):332-5. PubMed ID: 8667072
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and kinetics of holmium-166-chitosan complex (DW-166HC) in rats and mice.
Suzuki YS; Momose Y; Higashi N; Shigematsu A; Park KB; Kim YM; Kim JR; Ryu JM
J Nucl Med; 1998 Dec; 39(12):2161-6. PubMed ID: 9867162
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of lipiodol following hepatic arterial injection.
Hind RE; Loizidou M; Fleming J; Batty V; Birch S; Taylor I
Eur J Surg Oncol; 1992 Apr; 18(2):162-7. PubMed ID: 1316290
[TBL] [Abstract][Full Text] [Related]
12. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
Boschi A; Uccelli L; Duatti A; Colamussi P; Cittanti C; Filice A; Rose AH; Martindale AA; Claringbold PG; Kearney D; Galeotti R; Turner JH; Giganti M
Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
[TBL] [Abstract][Full Text] [Related]
13. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
Lee YS; Jeong JM; Kim YJ; Chang YS; Lee HJ; Son M; Lee JW; Yoon HS; Kang WJ; Lee DS; Chung JK; Lee MC; Suh YG
Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628
[TBL] [Abstract][Full Text] [Related]
14. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma.
Garin E; Denizot B; Noiret N; Lepareur N; Roux J; Moreau M; Herry JY; Bourguet P; Benoit JP; Lejeune JJ
Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868
[TBL] [Abstract][Full Text] [Related]
15. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Subramanian S; Sarma HD; Venkatesh M
Nucl Med Biol; 2006 May; 33(4):585-91. PubMed ID: 16720253
[TBL] [Abstract][Full Text] [Related]
16. [166Dy]Dy/166Ho hydroxide macroaggregates: an in vivo generator system for radiation synovectomy.
Ferro-Flores G; Hernández-Oviedo O; Arteaga de Murphy C; Tendilla JI; Monroy-Guzmán F; Pedraza-López M; Aldama-Alvarado K
Appl Radiat Isot; 2004 Dec; 61(6):1227-33. PubMed ID: 15388114
[TBL] [Abstract][Full Text] [Related]
17. Development and biodistribution of 188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs.
Garin E; Noiret N; Malbert C; Lepareur N; Roucoux A; Caulet-Maugendre S; Moisan A; Lecloirec J; Herry JY; Bourguet P
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):542-6. PubMed ID: 14691613
[TBL] [Abstract][Full Text] [Related]
18. Synthetic approaches and bio-distribution studies of [11C]methyl-phenidate.
Patt M; Solbach C; Wüllner U; Blocher A; Stahlschmidt A; Gündisch D; Kovar KA; Machulla HJ
J Pharm Pharm Sci; 2007; 10(2):312s-320s. PubMed ID: 17718934
[TBL] [Abstract][Full Text] [Related]
19. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
Moustapha ME; Ehrhardt GJ; Smith CJ; Szajek LP; Eckelman WC; Jurisson SS
Nucl Med Biol; 2006 Jan; 33(1):81-9. PubMed ID: 16459262
[TBL] [Abstract][Full Text] [Related]
20. Boron-lipiodol: a potential new drug for the treatment of liver tumors.
Lin WY; Chi CW; Ho YJ; Wu IC; Chung YT; Chen SD; Chou FI; Kai JJ; Lui WY; Chen TJ; Lin Y
Anticancer Res; 2002; 22(6C):3989-92. PubMed ID: 12553023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
